NCT00095810View on ClinicalTrials.gov

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Parkinson's DiseasePsychoses
Interventions
DRUG

aripiprazole

Tablets, Oral, 1-10mg, Once daily, 6 weeks.

Trial Locations (1)

Unknown

Local Institution, Albany

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00095810 - Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease | Biotech Hunter | Biotech Hunter